Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer
Status:
Completed
Trial end date:
2018-07-30
Target enrollment:
Participant gender:
Summary
This is a phase II,single center,prospective, single arm clinical trial. The objective is to
evaluate the efficacy and safety of routine therapy plus moxifloxacin in Advanced Breast
Cancer whose evaluation is stable disease with a trend of progression.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Anti-Bacterial Agents Antibiotics, Antitubercular Moxifloxacin Norgestimate, ethinyl estradiol drug combination